chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-02-15 AccNo: 0001387131-19-001283 Size: 65 KB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-02-15 AccNo: 0001387131-19-001282 Size: 65 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr制药(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-02-14 AccNo: 0001387131-19-001277 Size: 1 MB 网页链接
$Ohr制药(OHRP)$ 美东时间 2019-02-04 拆合股: 20合1 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-01-23 AccNo: 0001387131-19-000420 Size: 85 KB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-01-23 AccNo: 0001387131-19-000419 Size: 84 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to ...
$Ohr制药(OHRP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-01-03 AccNo: 0001387131-19-000051 Size: 4 MB 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-01-03 AccNo: 0001387131-19-000063 Size: 7 MB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-01-03 AccNo: 0001387131-19-000062 Size: 7 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directo...
$Ohr制药(OHRP)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2018-12-31 AccNo: 0001387131-18-007126 Size: 41 KB 网页链接